ARID1A in Gynecologic Precancers and Cancers

Reprod Sci. 2024 Aug;31(8):2150-2162. doi: 10.1007/s43032-024-01585-w. Epub 2024 May 13.

Abstract

The highest frequency of genetic alterations in the tumor suppressor ARID1A occurs in malignancies of the female reproductive tract. The prevalence of ARID1A alterations in gynecologic precancers and cancers is summarized from the literature, and the putative mechanisms of tumor suppressive action examined both in benign/precursor lesions including endometriosis and atypical hyperplasia and in malignancies of the ovary, uterus, cervix and vagina. ARID1A alterations in gynecologic cancers are usually loss-of-function mutations, resulting in diminished or absent protein expression. ARID1A deficiency results in pleiotropic downstream effects related not only to its role in transcriptional regulation as a SWI/SNF complex subunit, but also related to the functions of ARID1A in DNA replication and repair, immune modulation, cell cycle progression, endoplasmic reticulum (ER) stress and oxidative stress. The most promising actionable signaling pathway interactions and therapeutic vulnerabilities of ARID1A mutated cancers are presented with a critical review of the currently available experimental and clinical evidence. The role of ARID1A in response to chemotherapeutic agents, radiation therapy and immunotherapy is also addressed. In summary, the multi-faceted role of ARID1A mutation in precancer and cancer is examined through a clinical lens focused on development of novel preventive and therapeutic interventions for gynecological cancers.

Keywords: ARID1A; Chemoresistance; Disparities; Endometriosis; Gynecologic cancers; Immunotherapy; SWI/SNF complex; Targeted therapies.

Publication types

  • Review

MeSH terms

  • Animals
  • DNA-Binding Proteins* / genetics
  • DNA-Binding Proteins* / metabolism
  • Female
  • Genital Neoplasms, Female* / genetics
  • Genital Neoplasms, Female* / metabolism
  • Genital Neoplasms, Female* / therapy
  • Humans
  • Mutation
  • Precancerous Conditions / genetics
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology
  • Transcription Factors* / genetics
  • Transcription Factors* / metabolism

Substances

  • ARID1A protein, human
  • Transcription Factors
  • DNA-Binding Proteins